Contineum Therapeutics Ownership & Insider Activity

Contineum Therapeutics (CTNM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.5% of shares outstanding. Institutional investors hold 26.7%.

Shares Outstanding

37.621M

Shares Float

32.781M

Insider Shares Owned

174.180K

Insider % Owned

0.5%

Institutional Shares Held

10.053M

Institutional % Held

26.7%

Ownership Breakdown

Net Insider Activity by Month

Contineum Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 8, 2026	Carmine Stengone	CEO AND PRESIDENT	SELL-OPTIONS	—	$8.73	$39K
Aug 3, 2026	Carmine Stengone	CEO AND PRESIDENT	SELL-OPTIONS	—	$8.51	$38K
Jul 8, 2026	Daniel Lorrain	CHIEF SCIENTIFIC OFFICER	SELL-OPTIONS	—	$8.51	$16K
Jul 8, 2026	Carmine Stengone	CEO AND PRESIDENT	SELL-OPTIONS	—	$8.51	$37K
Jun 30, 2026	Daniel Lorrain	CHIEF SCIENTIFIC OFFICER	SELL	4.170K	$8.50	$561K
Jun 30, 2026	Tim Watkins	CMO & HEAD DEVELOPMENT	SELL-OPTIONS	—	$10.26	$125K
Jun 30, 2026	Carmine Stengone	CEO AND PRESIDENT	SELL-OPTIONS	—	$8.54	$149K
Jun 1, 2026	Daniel Lorrain	CHIEF SCIENTIFIC OFFICER	SELL	4.170K	$13.16	$55K
May 1, 2026	Daniel Lorrain	CHIEF SCIENTIFIC OFFICER	SELL	4.170K	$13.12	$55K